Профілактика порушень поведінкових реакцій щурів при застосуванні ноотропів з вальпроатом натрію [PDF]
Medičnì Perspektivi, 2013 Using of anticonvulsants can trigger a number of side effects, such as possible changes in behavior and emotional state of people with epilepsy, risk of unwarranted aggression, nervousness, discoordination, sleepiness, encephalopathies.
A. V. Ivanov
doaj +6 more sources
Bioequivalence study drug containing memantine [PDF]
Фармакокинетика и Фармакодинамика, 2013 At present, Russia has developed domestic analogue of Memantine Akatinol — Memaneyrin in the form of droplets which is pharmaceutically equivalent drug memantine Akatinol.
A. A. Karlitskaya +5 more
doaj +2 more sources
The dynamics of the cognitive and social functioning of patients with Alzheimer’s disease on therapy with antidementiv drugs: the results of observational study [PDF]
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018 The objective of this study was to evaluate the efficacy of the noojerone in patients with moderate Alzheimer disease and to compare obtained data with results of clinical trials of memantine. This was a 24-week open - label post-marketing clinical trial
N. M. Zalutskaya +2 more
doaj +2 more sources
Perspective for the use of adamantane-type drugs for the treatment of cerebrovascular and cardiovascular diseases [PDF]
, 2022 Adamantane-type drugs are widely used in pharmacology as antimicrobial, antitumor, immunosuppressive, hormonal, hypoglycemic, analgesic, anti-inflammatory and neurotropic drugs.
A. A. Shabalina, D. A. Abaimov
core +4 more sources
Регуляция ультрадианных ритмов двигательной активности олигопептидами, структурно родственными окситоцину [PDF]
, 2021 The pharmacological regulation of high-frequency rhythms of the behavioral activity (with a period of up to 1/2 hour) is an actual direction of modern medical science. The aim of the study was to assess the influence of oligopeptides structurally related
B. Dubovik V. +5 more
core +2 more sources
Оцінка стану фармацевтичного забезпечення хворих з деменцією при хворобі Альцгеймера в Україні у відповідності до міжнародних рекомендацій [PDF]
, 2022 The aim: to assess the state of pharmaceutical provision of patients with dementia in Alzheimer's disease in Ukraine in accordance with international recommendations. Materials and methods.
Fedotova, Maryna +9 more
core +3 more sources
Сравнительное изучение влияния производных адамантана на поведение мышей CD-1 c разным фенотипом устойчивости внимания [PDF]
, 2022 The effect of memantine (1 and 10 mg/kg/day), ladasten (50 mg/kg/day) and cyclantane (10 mg/kg/day) on the behavior of CD-1 mice differing in the phenotype of attention stability in the "closed enriched cross maze" test after three days of ...
G. I. Kovalev +5 more
core +4 more sources
Early diagnosis and treatment of Alzheimer's disease
Медицинский совет, 2015 There is an overview of literature devoted to the early diagnosis and treatment of Alzheimer's disease (AD). Medication and non-medication treatment methods for AD are discussed.
V. A. Parfyonov
doaj +1 more source
The clinical, diagnostic and therapeutic aspects of amnestic mild cognitive impairment
Медицинский совет, 2015 The article examines the prevalence, causes and main clinical manifestations of amnestic mild cognitive impairment - a syndrome which in most cases is the first manifestation of the neurodegenerative Alzheimer's disease.
N. N. Koberskaya
doaj +1 more source
Современная терапия психических расстройств, 2015 С учетом растущего количества публикаций об эффективности применения антагонистов Н2метил2д2Аспартат (NMDA2рецепторов) при шизофрении была проанализирована эффективность мемантина как дополнительного средства для лечения негативных симптомов при ...
Осадший, Ю.Ю. +3 more
doaj +1 more source